INCR

InterCure Ltd.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-60.3K
ExitQ1 2026
$60k
--
$1.20
Jim SimonsRenaissance Technologies
$49k64.6k shares
TrimQ1 2026
$17k
$0.7509
$1.20
Ken GriffinCitadel Advisors
$60k66.3k shares
AddQ4 2025
$39k
$0.91
$1.20
Jim SimonsRenaissance Technologies
$65k71.6k shares
TrimQ4 2025
$39k
$0.91
$1.20
Ken GriffinCitadel Advisors
$-39.4K
TrimQ3 2025
$39k
--
$1.20
Jim SimonsRenaissance Technologies
$32.6K
AddQ3 2025
$33k
--
$1.20

News

globenewswire.comInterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisitionglobenewswire.comJun 15globenewswire.comInterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisitionglobenewswire.comJun 15globenewswire.comInterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flowglobenewswire.comApr 30globenewswire.comInterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flowglobenewswire.comApr 30